ChEMBL ID: CHEMBL4297998
Mechanism of action: Killer cell immunoglobulin-like receptor 3DL2 antagonist
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Trials and conditions connected to LACUTAMAB